Etiometry has introduced Persistent Display functionality that allows hospital care givers to view near real-time patient trend information continuously by the bedside to improve care delivery. (See related press release).

Persistent Display is now bundled into our T3 Visualization & Data Aggregation software, an FDA-cleared software application to collect, store, and visualize ICU data in near real-time. T3 operates in two different “Modes” of visualization:

  • Individual User Mode
  • Persistent Display Mode

Individual User Mode initially presents a clinician with a display of the ICU patient census upon login to the T3 Software application. In this mode, the clinician can freely navigate among all patients in the census as well as choose to display the patient data. But Persistent Display Mode activates an always-on display of the data being captured by our T3 Software for one particular ICU bed location. It is most effectively used in the clinical workflow on a dedicated monitor at the bedside and/or just outside the room.

In T3 Persistent Display Mode, the patient data is displayed in a preconfigured “View” that has been optimized for a particular ICU environment. Currently there are Hemodynamic and Respiratory Views, and more organ system-specific views will be available in the future.

Persistent Display allows patient trend information to be continuously displayed at the bedside—such as on a wall-mounted monitor—to provide physicians and nursing staff with always-on, at-a-glance views into the clinical course of critically ill patients. The Persistent Display feature is immediately available with T3 Visualization & Data Aggregation software, and existing customers can implement Persistent Display at no extra costs.

Persistent Display was co-developed and is utilized by Boston Children’s Hospital in collaboration with Etiometry.

For more information, including bedside hardware requirements, deployment information and typical use cases, please send an email to to request it and we will email it to you shortly.


Share this post!

Give Us Feedback